NOWDiagnostics appoints Dr. Stephen Tang to its Board of Directors as Chairman

– USA, AR –  NOWDiagnostics, a developer of over-the-counter and point-of-care diagnostics tests and first-in-class technology and platforms, today announced the appointment of Dr. Stephen Tang (Ph.D.) as the chairman of the board of directors.

About Dr. Stephen S. Tang

Dr. Tang is a longtime veteran of the medical diagnostic industry. He led OraSure Technologies, Inc. (NASDAQ: OSUR), a pioneer and global leader in rapid at-home tests for HIV and COVID-19, for ten years as president and CEO, chairman of the board of directors, and chairman of the compensation committee. During his tenure as president and CEO, OraSure launched more FDA-cleared products, vastly expanded its sales, and developed and acquired more innovative products and services in its history.

“I am delighted and enthusiastic about joining the NOWDx team as their chairman of the board,” said Dr. Tang. “For many years, the medical diagnostic industry has sought to bring in-home tests from the lab to regulatory approval and widespread consumer use. More than ever, NOWDx brings us all closer to fulfilling that vision for better, more accessible healthcare for everyone with its in-home test, with in-home results in minutes platform. I am honored to join a talented and engaged board of directors to assist a highly capable and experienced team led by CEO Rob Weigle.”

Before leading OraSure, Dr. Tang was president and CEO of the University City Science Center in Philadelphia, the mid-Atlantic region’s premier innovation hub for life science companies. He also led Olympus America’s Life Sciences Group, which included laboratory diagnostic, microscope, and translational research instruments.

He earned his BS in Chemistry from the College of William & Mary, MS and Ph.D. in Chemical Engineering from Lehigh University, and an MBA for Executives from The Wharton School of Business at the University of Pennsylvania. In 2016, he was awarded a Doctor of Humane Letters (honoris causa) from Thomas Jefferson University (formerly Philadelphia University) and the Wagner Free Institute of Science.

Dr. Tang currently serves on the Boards of Directors of several nonprofit organizations, including the William & Mary Foundation, Population Services International, Lehigh University, Team Pennsylvania Foundation, and Life Sciences Pennsylvania.

About NOWDiagnostics

NOWDx develops and manufactures “Touch to Test” over-the-counter and point-of-care diagnostic tests that yield results in minutes. Its patented approach allows for virtually any immunological assay to be accurately performed onsite in one step using a tiny amount of capillary blood or, in some cases, saliva. NOWDx envisions a world where people have greater access to in-home testing with in-home results – in minutes. It is committed to changing healthcare by providing accessible, affordable, and accurate testing for all.

For more information:

- DisclaimerNews, data, and statements included in this release are intended exclusively for general information purposes. Talent4Boards does not guarantee that news is accurate or about the correct person and accepts neither liability for the consequences of the reader’s reliance, nor responsibility for the accuracy of the information. Nothing in this release should be considered for decisions about referred securities. Products and brand names may be trademarks or registered trademarks of their respective owners.